StockData
Reviva Pharmaceuticals Holdings, Inc. logo

Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock

RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$0.45−0.02 (-4.36%)

Close on Oct 19, 2026Market cap $5.94MP/E –Yield –

Earnings

Reviva Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 12, 2026
Q3 FY2026 · estimated, during market hours
Revenue, Q2 FY2026
–
EPS, Q2 FY2026
-$0.19
-$0.12 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Reviva Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 12, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 12, 2026during market hours––-$0.19Release
Q1 FY2026ended Mar 31, 2026May 13, 2026during market hours––-$0.46Release
Q4 FY2025ended Dec 31, 2025Mar 30, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 13, 2025during market hours––-$0.06Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025during market hours––-$0.12Release
Q1 FY2025ended Mar 31, 2025May 15, 2025during market hours–––Release
Q4 FY2024ended Dec 31, 2024Mar 31, 2025during market hours–––Release
Q3 FY2024ended Sep 30, 2024Nov 14, 2024during market hours––-$0.25Release
Q2 FY2024ended Jun 30, 2024Aug 14, 2024before the open–––Release
Q1 FY2024ended Mar 31, 2024May 14, 2024before the open–––Release
Q4 FY2023ended Dec 31, 2023Apr 15, 2024before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Reviva Pharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Reviva Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Reviva Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Update
  5. Results
  6. Update
  7. Update
  8. Update
  9. Results
  10. Update
  11. Update
  12. Results
  13. Update
  14. Update
  15. Update

See a number that looks wrong?